HEATHER EBERLEIN: Open Payments
NPI 1467288548 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$869 in 31 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $112 · 2025 $869
Food & beverage: $869
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 8 | $178 |
| Biosense Webster, Inc. | 1 | $148 |
| E.R. Squibb & Sons, L.L.C. | 8 | $143 |
| AstraZeneca Pharmaceuticals LP | 2 | $140 |
| PFIZER INC. | 4 | $81 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
| ABIOMED | 1 | $30 |
| SCPHARMACEUTICALS INC. | 1 | $29 |
| Novo Nordisk Inc | 1 | $25 |
| AltaThera Pharmaceuticals LLC | 1 | $22 |
Products named: VERQUVO, CARTO 3, ELIQUIS, WAINUA, CAMZYOS, Kerendia, FUROSCIX, Ozempic.
Industry payments across GA — which companies pay providers there.
